{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:44:42Z","timestamp":1791247482782,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alzheimer\u2019s Association","award":["#NIRP-12-258855"],"award-info":[{"award-number":["#NIRP-12-258855"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disease characterized by extensive neurodegeneration and consequent severe memory loss. Apolipoprotein E4 (ApoE4) is the strongest genetic risk factor for AD, with its pathological effects linked to structural instability and altered interactions with lipids and other important disease proteins including amyloid beta (A\u03b2) and tau (\u03c4). Therefore, correcting and stabilizing the ApoE4 structure has emerged as a promising therapeutic strategy for mitigating its detrimental effects. In this study, we investigated naturally occurring bioavailable flavonoids as ApoE4 stabilizers, focusing on their potential to modulate ApoE4 structure and function. A comprehensive investigation of a focused database using our integrated computational and experimental screening protocol led to the identification of Isobavachin as a potential corrector and stabilizer of ApoE4 structure. In addition, a few other bioavailable flavonoids with similar stabilizing properties were identified, albeit to a much lesser extent as compared to Isobavachin. The findings support the therapeutic potential of flavonoids as ApoE4 modulators and highlight Isobavachin as a lead candidate for further preclinical evaluation. These results provide new insights into the pharmacological targeting of ApoE4 and open avenues for the development of flavonoid-based, ApoE-directed therapies for AD.<\/jats:p>","DOI":"10.3390\/molecules30040940","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:36:19Z","timestamp":1739867779000},"page":"940","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1354-0386","authenticated-orcid":false,"given":"Sachin P.","family":"Patil","sequence":"first","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"},{"name":"Department of Chemical Engineering, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella R.","family":"Kuehn","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3428-6144","authenticated-orcid":false,"given":"Christina","family":"McCullough","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Bates","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil","family":"Hazim","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Diallo","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomie","family":"Francois","sequence":"additional","affiliation":[{"name":"NanoBio Laboratory, Widener University, Chester, PA 19013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Chapter 13-Alzheimer\u2019s disease","volume":"167","author":"Gonzalez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tins.2023.03.005","article-title":"Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer\u2019s disease","volume":"46","author":"Lee","year":"2023","journal-title":"Trends Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neulet.2005.05.003","article-title":"Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons","volume":"384","author":"Patil","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2006.07.015","article-title":"Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons","volume":"406","author":"Patil","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1460-9568.2007.05797.x","article-title":"Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons","volume":"26","author":"Patil","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","article-title":"Amyloid \u03b2-protein and beyond: The path forward in Alzheimer\u2019s disease","volume":"61","author":"Walsh","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/d41573-023-00004-0","article-title":"FDA approves second anti-amyloid antibody for Alzheimer disease","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer\u2019s Disease Therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: From atherosclerosis to Alzheimer\u2019s disease and beyond","volume":"10","author":"Mahley","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110865","DOI":"10.1016\/j.mehy.2022.110865","article-title":"Alzheimer\u2019s neuroinflammation: A crosstalk between immune checkpoint PD1-PDL1 and ApoE-Heparin interactions?","volume":"164","author":"Patil","year":"2022","journal-title":"Med. Hypotheses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.mehy.2012.01.015","article-title":"ApoE: The link between Alzheimer\u2019s-related glucose hypometabolism and A\u03b2 deposition?","volume":"78","author":"Patil","year":"2012","journal-title":"Med. Hypotheses"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Patil, S.P., and Kuehn, B.R. (2024). Discovery of Small Molecule Glycolytic Stimulants for Enhanced ApoE Lipidation in Alzheimer\u2019s Disease Cell Model. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040491"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Konings","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structure and function: Structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/acs.jmedchem.9b00178","article-title":"Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer","volume":"62","author":"Petros","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1021\/acs.jcim.3c00365","article-title":"DCABM-TCM: A Database of Constituents Absorbed into the Blood and Metabolites of Traditional Chinese Medicine","volume":"63","author":"Liu","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural Products as Sources of New Drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/np900633j","article-title":"Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance","volume":"73","author":"Patil","year":"2010","journal-title":"J. Nat. Prod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2013.09.008","article-title":"Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons","volume":"554","author":"Patil","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1021\/ci700376c","article-title":"Optimization of high throughput virtual screening by combining shape-matching and docking methods","volume":"48","author":"Lee","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10822-014-9732-4","article-title":"Prospective virtual screening for novel p53-MDM2 inhibitors using ultrafast shape recognition","volume":"28","author":"Patil","year":"2014","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/cmdc.202100264","article-title":"Identification of the FDA-Approved Drug Pyrvinium as a Small-Molecule Inhibitor of the PD-1\/PD-L1 Interaction","volume":"16","author":"Fattakhova","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of shape-matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72 Pt A","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease","volume":"277","author":"Morrow","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-023-00620-9","article-title":"Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer\u2019s Disease drug candidate","volume":"18","author":"Nemergut","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Morante-Carriel, J., N\u00e1jera, H., Samper-Herrero, A., \u017divkovi\u0107, S., Mart\u00ednez-Esteso, M.J., Mart\u00ednez-M\u00e1rquez, A., Sell\u00e9s-Marchart, S., Obrebska, A., and Bru-Mart\u00ednez, R. (2024). Therapeutic Potential of Prenylated Flavonoids of the Fabaceae Family in Medicinal Chemistry: An Updated Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252313036"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.phymed.2017.12.002","article-title":"Plasma pharmacokinetics and cerebral nuclei distribution of major constituents of Psoraleae fructus in rats after oral administration","volume":"38","author":"Yang","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","article-title":"Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice","volume":"124","author":"Sullivan","year":"2004","journal-title":"Neuroscience"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Patil, S., Balu, D., Melrose, J., and Chan, C. (2008). Brain region-specificity of palmitic acid-induced abnormalities associated with Alzheimer\u2019s disease. BMC Res. Notes, 1.","DOI":"10.1186\/1756-0500-1-20"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2174\/138161209788682479","article-title":"Drug-Like Property Concepts in Pharmaceutical Design","volume":"15","author":"Di","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and the Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The Protein Data Bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/4\/940\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:36:35Z","timestamp":1760027795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/4\/940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["molecules30040940"],"URL":"https:\/\/doi.org\/10.3390\/molecules30040940","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}